Advertisement

Chronic Villitis

  • Chong Jai KimEmail author
  • Jung-Sun Kim
Chapter

Abstract

An anatomical and metabolic interface between the mother and the fetus, villous placenta (placental disc) is of the utmost importance for the well-being of the fetus. In this context, chronic villitis leading to destruction of chorionic villi has robust clinical implications. The primary pathology of chronic villitis is the infiltration of chronic inflammatory cells (lymphocytes, plasma cells, and histiocytes) associated with destruction of the chorionic villi. A unique and scientifically important feature of chronic villitis is the fact that maternal lymphocytes are primary players of inflammation in the fetal chorionic villi in many occasions. Aetiologies of chronic villitis documented so far are infections by various organisms, yet it is evident that the most common form of chronic villitis, known as villitis of unknown aetiology, results from maternal immune responses against the fetus. This chapter will describe the pathological findings of representative examples of infectious chronic villitis and villitis of unknown aetiology.

Keywords

Placenta Chorionic villi Villitis Syphilis Cytomegalovirus Parvovirus B19 Alloimmune 

References

  1. 1.
    Schwartz DA. Viral infection, proliferation, and hyperplasia of Hofbauer cells and absence of inflammation characterize the placental pathology of fetuses with congenital Zika virus infection. Arch Gynecol Obstet. 2017;295:1361–8.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Nakamura Y, Sakuma S, Ohta Y, Kawano K, Hashimoto T. Detection of the human cytomegalovirus gene in placental chronic villitis by polymerase chain reaction. Hum Pathol. 1994;25:815–8.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Bowen V, Su J, Torrone E, Kidd S, Weinstock H. Increase in incidence of congenital syphilis—United States, 2012-2014. MMWR. 2015;64:1241–5.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Grossman J 3rd. Congenital syphilis. Teratology. 1977;16:217–9.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Judge DM, Tafari N, Naeye RL, Marboe C. Congenital syphilis and perinatal mortality. Pediatr Pathol. 1986;5:411–20.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Malan AF, Woods DL, Van der Elst CW, Meyer MP. Relative placental weight in congenital syphilis. Placenta. 1990;11:3–6.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Genest DR, Choi-Hong SR, Tate JE, Qureshi F, Jacques SM, Crum C. Diagnosis of congenital syphilis from placental examination: comparison of histopathology, Steiner stain, and polymerase chain reaction for Treponema pallidum DNA. Hum Pathol. 1996;27:366–72.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Braunstein H. Congenital syphilis in aborted second trimester fetus: diagnosis by histological study. J Clin Pathol. 1978;31:265–7.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Walter P, Blot P, Ivanoff B. The placental lesions in congenital syphilis. A study of six cases. Virchows Arch A Pathol Anat Histol. 1982;397:313–26.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Ricci JM, Fojaco RM, O'Sullivan MJ. Congenital syphilis: the University of Miami/Jackson Memorial Medical Center experience, 1986-1988. Obstet Gynecol. 1989;74:687–93.PubMedGoogle Scholar
  11. 11.
    Russell P, Altshuler G. Placental abnormalities of congenital syphilis. A neglected aid to diagnosis. Am J Dis Child. 1974;128:160–3.PubMedCrossRefGoogle Scholar
  12. 12.
    Qureshi F, Jacques SM, Reyes MP. Placental histopathology in syphilis. Hum Pathol. 1993;24:779–84.PubMedCrossRefGoogle Scholar
  13. 13.
    Kapur P, Rakheja D, Gomez AM, Sheffield J, Sanchez P, Rogers BB. Characterization of inflammation in syphilitic villitis and in villitis of unknown etiology. Pediatr Dev Pathol. 2004;7:453–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Fojaco RM, Hensley GT, Moskowitz L. Congenital syphilis and necrotizing funisitis. JAMA. 1989;261:1788–90.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Knowles S, Frost T. Umbilical cord sclerosis as an indicator of congenital syphilis. J Clin Pathol. 1989;42:1157–9.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Craver RD, Baldwin VJ. Necrotizing funisitis. Obstet Gynecol. 1992;79:64–70.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Kerr DA. Improved Warthin-Starry method of staining spirochetes in tissue sections. Am J Clin Pathol. 1938;8:63–7.CrossRefGoogle Scholar
  18. 18.
    Epstein H, King CR. Diagnosis of congenital syphilis by immunofluorescence following fetal death in utero. Am J Obstet Gynecol. 1985;152:689–90.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Ohyama M, Itani Y, Tanaka Y, Goto A, Sasaki Y. Syphilitic placentitis: demonstration of Treponema pallidum by immunoperoxidase staining. Virchows Arch A Pathol Anat Histopathol. 1990;417:343–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Duff P. A thoughtful algorithm for the accurate diagnosis of primary CMV infection in pregnancy. Am J Obstet Gynecol. 2007;196:196–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Amirhessami-Aghili N, Manalo P, Hall MR, Tibbitts FD, Ort CA, Afsari A. Human cytomegalovirus infection of human placental explants in culture: histologic and immunohistochemical studies. Am J Obstet Gynecol. 1987;156:1365–74.PubMedCrossRefGoogle Scholar
  22. 22.
    Schleiss MR. Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infect Disord Drug Targets. 2011;11:449–65.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Doyle M, Atkins JT, Rivera-Matos IR. Congenital cytomegalovirus infection in infants infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1996;15:1102–6.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    McDonagh S, Maidji E, Chang HT, Pereira L. Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis. J Clin Virol. 2006;35:210–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Benirschke K, Burton GJ, Baergen RN. Pathology of the human placenta. 6th ed. Heidelberg: Springer-Verlag; 2012.CrossRefGoogle Scholar
  26. 26.
    Garcia AG, Fonseca EF, Marques RL, Lobato YY. Placental morphology in cytomegalovirus infection. Placenta. 1989;10:1–18.PubMedCrossRefGoogle Scholar
  27. 27.
    Mostoufi-zadeh M, Driscoll SG, Biano SA, Kundsin RB. Placental evidence of cytomegalovirus infection of the fetus and neonate. Arch Pathol Lab Med. 1984;108:403–6.PubMedGoogle Scholar
  28. 28.
    Muhlemann K, Miller RK, Metlay L, Menegus MA. Cytomegalovirus infection of the human placenta: an immunocytochemical study. Hum Pathol. 1992;23:1234–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Tabata T, Petitt M, Fang-Hoover J, Zydek M, Pereira L. Persistent cytomegalovirus infection in amniotic membranes of the human Placenta. Am J Pathol. 2016;186:2970–86.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Sachdev R, Nuovo GJ, Kaplan C, Greco MA. In situ hybridization analysis for cytomegalovirus in chronic villitis. Pediatr Pathol. 1990;10:909–17.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Wolber RA, Lloyd RV. Cytomegalovirus detection by nonisotopic in situ DNA hybridization and viral antigen immunostaining using a two-color technique. Hum Pathol. 1988;19:736–41.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Chehab FF, Xiao X, Kan YW, Yen TS. Detection of cytomegalovirus infection in paraffin-embedded tissue specimens with the polymerase chain reaction. Mod Pathol. 1989;2:75–8.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Nyman M, Tolfvenstam T, Petersson K, Krassny C, Skjoldebrand-Sparre L, Broliden K. Detection of human parvovirus B19 infection in first-trimester fetal loss. Obstet Gynecol. 2002;99:795–8.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Skjoldebrand-Sparre L, Tolfvenstam T, Papadogiannakis N, Wahren B, Broliden K, Nyman M. Parvovirus B19 infection: association with third-trimester intrauterine fetal death. BJOG. 2000;107:476–80.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service working party on fifth disease. BMJ. 1990;300:1166–70.CrossRefGoogle Scholar
  36. 36.
    Hartwig NG, Vermeij-Keers C, Van Elsacker-Niele AM, Fleuren GJ. Embryonic malformations in a case of intrauterine parvovirus B19 infection. Teratology. 1989;39:295–302.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Rogers BB. Histopathologic variability of finding erythroid inclusions with intrauterine parvovirus B19 infection. Pediatr Pathol. 1992;12:883–9.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Knisely AS. Parvovirus B19 infection in the fetus. Lancet. 1990;336:443.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Pasquinelli G, Bonvicini F, Foroni L, Salfi N, Gallinella G. Placental endothelial cells can be productively infected by Parvovirus B19. J Clin Virol. 2009;44:33–8.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Garcia AG, Pegado CS, Cubel Rde C, Fonseca ME, Sloboda I, Nascimento JP. Feto-placentary pathology in human parvovirus B19 infection. Rev Inst Med Trop Sao Paulo. 1998;40:145–50.PubMedCrossRefGoogle Scholar
  41. 41.
    Hassam S, Briner J, Tratschin JD, Siegl G, Heitz PU. In situ hybridization for the detection of human parvovirus B19 nucleic acid sequences in paraffin-embedded specimens. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;59:257–61.PubMedCrossRefGoogle Scholar
  42. 42.
    Li JJ, Henwood T, Van Hal S, Charlton A. Parvovirus infection: an immunohistochemical study using fetal and placental tissue. Pediatr Dev Pathol. 2015;18:30–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Knisely AS, O'Shea PA, McMillan P, Singer DB, Magid MS. Electron microscopic identification of parvovirus virions in erythroid-line cells in fatal hydrops fetalis. Pediatr Pathol. 1988;8:163–70.PubMedCrossRefGoogle Scholar
  44. 44.
    Rogers BB, Rogers ZR, Timmons CF. Polymerase chain reaction amplification of archival material for parvovirus B19 in children with transient erythroblastopenia of childhood. Pediatr Pathol Lab Med. 1996;16:471–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Yamakawa Y, Oka H, Hori S, Arai T, Izumi R. Detection of human parvovirus B19 DNA by nested polymerase chain reaction. Obstet Gynecol. 1995;86:126–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Gramatges MM, Fani P, Nadeau K, Pereira S, Jeng MR. Neonatal alloimmune thrombocytopenia and neutropenia associated with maternal human leukocyte antigen antibodies. Pediatr Blood Cancer. 2009;53:97–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Lewin S, Bussel JB. Review of fetal and neonatal immune cytopenias. Clin Adv Hematol Oncol. 2015;13:35–43.PubMedGoogle Scholar
  48. 48.
    Myerson D, Parkin RK, Benirschke K, Tschetter CN, Hyde SR. The pathogenesis of villitis of unknown etiology: analysis with a new conjoint immunohistochemistry-in situ hybridization procedure to identify specific maternal and fetal cells. Pediatr Dev Pathol. 2006;9:257–65.PubMedCrossRefGoogle Scholar
  49. 49.
    Kim MJ, Romero R, Kim CJ, et al. Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease. J Immunol. 2009;182:3919–27.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Lee J, Romero R, Xu Y, et al. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS One. 2011;6:e16806.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Lee KA, Kim YW, Shim JY, et al. Distinct patterns of C4d immunoreactivity in placentas with villitis of unknown etiology, cytomegaloviral placentitis, and infarct. Placenta. 2013;34:432–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Rudzinski E, Gilroy M, Newbill C, Morgan T. Positive C4d immunostaining of placental villous syncytiotrophoblasts supports host-versus-graft rejection in villitis of unknown etiology. Pediatr Dev Pathol. 2013;16:7–13.PubMedCrossRefGoogle Scholar
  53. 53.
    Gersell DJ, Phillips NJ, Beckerman K. Chronic chorioamnionitis: a clinicopathologic study of 17 cases. Int J Gynecol Pathol. 1991;10:217–29.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Jacques SM, Qureshi F. Chronic chorioamnionitis: a clinicopathologic and immunohistochemical study. Hum Pathol. 1998;29:1457–61.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Khong TY, Bendon RW, Qureshi F, et al. Chronic deciduitis in the placental basal plate: definition and interobserver reliability. Hum Pathol. 2000;31:292–5.PubMedCrossRefGoogle Scholar
  56. 56.
    Labarrere CA, Catoggio LJ, Mullen EG, Althabe OH. Placental lesions in maternal autoimmune diseases. Am J Reprod Immunol Microbiol. 1986;12:78–86.PubMedCrossRefGoogle Scholar
  57. 57.
    Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998;179:194–202.PubMedCrossRefGoogle Scholar
  58. 58.
    Madsen-Bouterse SA, Romero R, Tarca AL, et al. The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol. 2010;63:73–92.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Lee J, Romero R, Chaiworapongsa T, et al. Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response. Am J Reprod Immunol. 2013;70:265–84.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Boog G. Chronic villitis of unknown etiology. Eur J Obstet Gynecol Reprod Biol. 2008;136:9–15.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Knox WF, Fox H. Villitis of unknown aetiology: its incidence and significance in placentae from a British population. Placenta. 1984;5:395–402.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Redline RW, Abramowsky CR. Clinical and pathologic aspects of recurrent placental villitis. Hum Pathol. 1985;16:727–31.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol. 2007;38:1439–46.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Feeley L, Mooney EE. Villitis of unknown aetiology: correlation of recurrence with clinical outcome. J Obstet Gynaecol. 2010;30:476–9.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Styer AK, Parker HJ, Roberts DJ, Palmer-Toy D, Toth TL, Ecker JL. Placental villitis of unclear etiology during ovum donor in vitro fertilization pregnancy. Am J Obstet Gynecol. 2003;189:1184–6.PubMedCrossRefGoogle Scholar
  66. 66.
    Perni SC, Predanic M, Cho JE, Baergen RN. Placental pathology and pregnancy outcomes in donor and non-donor oocyte in vitro fertilization pregnancies. J Perinat Med. 2005;33:27–32.PubMedCrossRefGoogle Scholar
  67. 67.
    Labarrere C, Althabe O. Chronic villitis of unknown aetiology in recurrent intrauterine fetal growth retardation. Placenta. 1987;8:167–73.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Yusuf K, Kliman HJ. The fetus, not the mother, elicits maternal immunologic rejection: lessons from discordant dizygotic twin placentas. J Perinat Med. 2008;36:291–6.PubMedCrossRefGoogle Scholar
  69. 69.
    Chan JS. Villitis of unknown etiology and massive chronic intervillositis. Surg Pathol Clin. 2013;6:115–26.PubMedCrossRefGoogle Scholar
  70. 70.
    Nowak C, Joubert M, Jossic F, et al. Perinatal prognosis of pregnancies complicated by placental chronic villitis or intervillositis of unknown etiology and combined lesions: about a series of 178 cases. Placenta. 2016;44:104–8.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Kim JS, Romero R, Kim MR, et al. Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiology. Histopathology. 2008;52:457–64.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Russell P. Inflammatory lesions of the human placenta. III. The histopathology of villitis of unknown aetiology. Placenta. 1980;1:227–44.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7:443–52.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Katzman PJ, Murphy SP, Oble DA. Immunohistochemical analysis reveals an influx of regulatory T cells and focal trophoblastic STAT-1 phosphorylation in chronic villitis of unknown etiology. Pediatr Dev Pathol. 2011;14:284–93.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Kim EN, Yoon BH, Lee JY, et al. Placental C4d deposition is a feature of defective placentation: observations in cases of preeclampsia and miscarriage. Virchows Arch. 2015;466:717–25.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Lee JY, Hong JS, Kim EN, et al. Placental C4d as a common feature of chromosomally normal and abnormal miscarriages. Virchows Arch. 2014;464:613–20.PubMedCrossRefGoogle Scholar
  77. 77.
    Becroft DM, Thompson JM, Mitchell EA. Placental villitis of unknown origin: epidemiologic associations. Am J Obstet Gynecol. 2005;192:264–71.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Kovo M, Ganer Herman H, Gold E, Bar J, Schreiber L. Villitis of unknown etiology—prevalence and clinical associations. J Matern Fetal Neonatal Med. 2016;29:3110–4.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    De Tar MW, Klohe E, Grosset A, Rau T. Neonatal alloimmune thrombocytopenia with HLA alloimmunization: case report with immunohematologic and placental findings. Pediatr Dev Pathol. 2002;5:200–5.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Althaus J, Weir EG, Askin F, Kickler TS, Blakemore K. Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy. Am J Obstet Gynecol. 2005;193:1100–4.PubMedCrossRefGoogle Scholar
  81. 81.
    Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol. 2005;192:452–7.PubMedCrossRefGoogle Scholar
  82. 82.
    Torrance HL, Bloemen MC, Mulder EJ, et al. Predictors of outcome at 2 years of age after early intrauterine growth restriction. Ultrasound Obstet Gynecol. 2010;36:171–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Pathology, Asan Medical CenterUniversity of Ulsan College of MedicineSeoulSouth Korea
  2. 2.Department of Pathology and Translational Genomics, Samsung Medical CenterSungkyunkwan Univerisity School of MedicineSeoulSouth Korea

Personalised recommendations